Copyright
©The Author(s) 2022.
World J Clin Cases. Jan 14, 2022; 10(2): 469-476
Published online Jan 14, 2022. doi: 10.12998/wjcc.v10.i2.469
Published online Jan 14, 2022. doi: 10.12998/wjcc.v10.i2.469
Index | Ki-67 Protein positive (n = 54) | Ki-67 Protein negative (n =32) | χ2 | P value |
Age (yr) | 1.173 | 0.279 | ||
≥ 60 | 29 (53.70) | 21 (65.63) | ||
< 60 | 25 (46.30) | 11 (34.38) | ||
Gender | 0.844 | 0.358 | ||
Male | 24 (44.44) | 11 (34.38) | ||
Female | 30 (55.56) | 21 (65.63) | ||
Lesion site | 1.250 | 0.535 | ||
Gastric antrum | 7 (12.96) | 5 (15.63) | ||
Body of stomach | 14 (25.93) | 5 (15.63) | ||
Base of stomach | 33 (61.11) | 22 (68.75) | ||
Risk classification | 7.380 | 0.025 | ||
Very low risk | 15 (27.78) | 17 (53.13) | ||
Low risk | 26 (48.15) | 13 (40.63) | ||
Medium and high risk | 13 (24.07) | 2 (6.25) | ||
Mitosis | 5.156 | 0.023 | ||
≤ 5 | 33 (61.11) | 27 (84.38) | ||
> 5 | 21 (38.89) | 5 (15.63) | ||
Lesion diameter (cm) | 1.764 | 0.184 | ||
> 2.0 cm | 38 (70.37) | 18 (56.25) | ||
≤ 2.0 cm | 16 (29.63) | 14 (43.75) |
Index | CD44 protein positive (n = 59) | CD44 protein negative (n = 27) | χ2 | P value |
Age (yr) | 1.176 | 0.278 | ||
≥ 60 | 32 (54.24) | 18 (66.67) | ||
< 60 | 27 (45.76) | 9 (33.33) | ||
Gender | 0.884 | 0.347 | ||
Male | 26 (44.07) | 9 (33.33) | ||
Female | 33 (55.93) | 18 (66.67) | ||
Lesion site | 1.283 | 0.256 | ||
Gastric antrum | 7 (11.86) | 5 (18.52) | ||
Body of stomach | 12 (20.34) | 7 (25.93) | ||
Base of stomach | 40 (67.80) | 15 (55.56) | ||
Risk classification | 6.534 | 0.038 | ||
Very low risk | 18 (30.51) | 14 (51.85) | ||
Low risk | 27 (45.76) | 12 (44.44) | ||
Medium and high risk | 14 (23.73) | 1 (3.70) | ||
Mitosis | 6.822 | 0.009 | ||
≤ 5 | 36 (61.02) | 24 (88.89) | ||
> 5 | 23 (38.98) | 3 (11.11) | ||
Lesion diameter (cm) | 1.584 | 0.208 | ||
> 2.0 cm | 41 (69.49) | 15 (55.56) | ||
≤ 2.0 cm | 18 (30.51) | 12 (44.44) |
n | MVD (/Hp) | t | P value | |
Ki-67 expression | 0.889 | 0.377 | ||
Positive | 54 | 15.41 ± 3.10 | ||
Negative | 32 | 14.82 ± 2.75 | ||
CD44 expression | 3.003 | 0.004 | ||
Positive | 59 | 15.92 ± 2.94 | ||
Negative | 27 | 13.86 ± 2.98 |
- Citation: Ma B, Huang XT, Zou GJ, Hou WY, Du XH. Relationship between Ki-67 and CD44 expression and microvascular formation in gastric stromal tumor tissues. World J Clin Cases 2022; 10(2): 469-476
- URL: https://www.wjgnet.com/2307-8960/full/v10/i2/469.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i2.469